Cargando…

Smart Polymeric Nanoparticles in Cancer Immunotherapy

Cancer develops with unexpected mutations and causes death in many patients. Among the different cancer treatment strategies, immunotherapy is promising with the benefits of high specificity and accuracy, as well as modulating immune responses. Nanomaterials can be used to formulate drug delivery ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Zhecheng, Shen, Xingyue, Yu, Han, Tu, Haohong, Chittasupho, Chuda, Zhao, Yunqi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10056399/
https://www.ncbi.nlm.nih.gov/pubmed/36986636
http://dx.doi.org/10.3390/pharmaceutics15030775
_version_ 1785016112242491392
author Yu, Zhecheng
Shen, Xingyue
Yu, Han
Tu, Haohong
Chittasupho, Chuda
Zhao, Yunqi
author_facet Yu, Zhecheng
Shen, Xingyue
Yu, Han
Tu, Haohong
Chittasupho, Chuda
Zhao, Yunqi
author_sort Yu, Zhecheng
collection PubMed
description Cancer develops with unexpected mutations and causes death in many patients. Among the different cancer treatment strategies, immunotherapy is promising with the benefits of high specificity and accuracy, as well as modulating immune responses. Nanomaterials can be used to formulate drug delivery carriers for targeted cancer therapy. Polymeric nanoparticles used in the clinic are biocompatible and have excellent stability. They have the potential to improve therapeutic effects while significantly reducing off-target toxicity. This review classifies smart drug delivery systems based on their components. Synthetic smart polymers used in the pharmaceutical industry, including enzyme-responsive, pH-responsive, and redox-responsive polymers, are discussed. Natural polymers derived from plants, animals, microbes, and marine organisms can also be used to construct stimuli-responsive delivery systems with excellent biocompatibility, low toxicity, and biodegradability. The applications of smart or stimuli-responsive polymers in cancer immunotherapies are discussed in this systemic review. We summarize different delivery strategies and mechanisms that can be used in cancer immunotherapy and give examples of each case.
format Online
Article
Text
id pubmed-10056399
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-100563992023-03-30 Smart Polymeric Nanoparticles in Cancer Immunotherapy Yu, Zhecheng Shen, Xingyue Yu, Han Tu, Haohong Chittasupho, Chuda Zhao, Yunqi Pharmaceutics Review Cancer develops with unexpected mutations and causes death in many patients. Among the different cancer treatment strategies, immunotherapy is promising with the benefits of high specificity and accuracy, as well as modulating immune responses. Nanomaterials can be used to formulate drug delivery carriers for targeted cancer therapy. Polymeric nanoparticles used in the clinic are biocompatible and have excellent stability. They have the potential to improve therapeutic effects while significantly reducing off-target toxicity. This review classifies smart drug delivery systems based on their components. Synthetic smart polymers used in the pharmaceutical industry, including enzyme-responsive, pH-responsive, and redox-responsive polymers, are discussed. Natural polymers derived from plants, animals, microbes, and marine organisms can also be used to construct stimuli-responsive delivery systems with excellent biocompatibility, low toxicity, and biodegradability. The applications of smart or stimuli-responsive polymers in cancer immunotherapies are discussed in this systemic review. We summarize different delivery strategies and mechanisms that can be used in cancer immunotherapy and give examples of each case. MDPI 2023-02-26 /pmc/articles/PMC10056399/ /pubmed/36986636 http://dx.doi.org/10.3390/pharmaceutics15030775 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Yu, Zhecheng
Shen, Xingyue
Yu, Han
Tu, Haohong
Chittasupho, Chuda
Zhao, Yunqi
Smart Polymeric Nanoparticles in Cancer Immunotherapy
title Smart Polymeric Nanoparticles in Cancer Immunotherapy
title_full Smart Polymeric Nanoparticles in Cancer Immunotherapy
title_fullStr Smart Polymeric Nanoparticles in Cancer Immunotherapy
title_full_unstemmed Smart Polymeric Nanoparticles in Cancer Immunotherapy
title_short Smart Polymeric Nanoparticles in Cancer Immunotherapy
title_sort smart polymeric nanoparticles in cancer immunotherapy
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10056399/
https://www.ncbi.nlm.nih.gov/pubmed/36986636
http://dx.doi.org/10.3390/pharmaceutics15030775
work_keys_str_mv AT yuzhecheng smartpolymericnanoparticlesincancerimmunotherapy
AT shenxingyue smartpolymericnanoparticlesincancerimmunotherapy
AT yuhan smartpolymericnanoparticlesincancerimmunotherapy
AT tuhaohong smartpolymericnanoparticlesincancerimmunotherapy
AT chittasuphochuda smartpolymericnanoparticlesincancerimmunotherapy
AT zhaoyunqi smartpolymericnanoparticlesincancerimmunotherapy